title: Intraocular pressure in patients with human immunodeficiency virus and treated with highly active antiretroviral therapy.
abstract: OBJECTIVE
  To compare the intraocular pressure (IOP) of patients infected with human immunodeficiency virus (HIV) and treated with highly active antiretroviral therapy (HAART) to a control group and to determine whether HAART reverses the previously reported reduction in IOP associated with HIV infection.
  
  
  METHODS
  Retrospective case control study.
  
  
  METHODS
  Review of patients with HIV infection on HAART compared with a matched control group.
  
  
  RESULTS
  Among 64 patients and 56 control subjects, no significant difference in IOP was found (P =.520), nor was correlation noted between IOP and either CD4+ T-lymphocyte counts, or viral load.
  
  
  CONCLUSIONS
  When HIV infection is treated with HAART, IOP is not significantly different from that of control subjects.
authors.affiliation: Department of Ophthalmology, University of Washington, Seattle, Washington 98195, USA.
authors.forename: Roy J
authors.initials: RJ
authors.lastname: Park
authors.forename: Raghu C
authors.initials: RC
authors.lastname: Mudumbai
authors.forename: Philip P
authors.initials: PP
authors.lastname: Chen
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D016022:Case-Control Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D008297:Male; D012189:Retrospective Studies
chemical_list: D019380:Anti-HIV Agents